Tag archive for ‘NuPathe Inc. (Nasdaq:PATH)’
Press Release On Tuesday, January 21st, 2014

Teva Expands CNS Specialty Business With Acquisition of NuPathe for $144 Million

Press Release JERUSALEM–(BUSINESS WIRE)–Jan. 21, 2014– Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) today announced that it has entered into a definitive agreement under which Teva More...

Email:

Delivered by FeedBurner